298 related articles for article (PubMed ID: 32232184)
1. The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease.
Kravets I; Mallipattu SK
J Endocr Soc; 2020 Apr; 4(4):bvaa029. PubMed ID: 32232184
[TBL] [Abstract][Full Text] [Related]
2. Research progress on exosomes in podocyte injury associated with diabetic kidney disease.
Li J; Zheng S; Ma C; Chen X; Li X; Li S; Wang P; Chen P; Wang Z; Li W; Liu Y
Front Endocrinol (Lausanne); 2023; 14():1129884. PubMed ID: 37020588
[TBL] [Abstract][Full Text] [Related]
3. Research advance in the mechanism for oxidative stress-induced podocyte injury in diabetic kidney disease.
Ao L; Xie Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1403-1408. PubMed ID: 35232911
[TBL] [Abstract][Full Text] [Related]
4. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
[TBL] [Abstract][Full Text] [Related]
5. Glomerular endothelial cell injury and cross talk in diabetic kidney disease.
Fu J; Lee K; Chuang PY; Liu Z; He JC
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387
[TBL] [Abstract][Full Text] [Related]
6. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
7. CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
Zuo F; Wang Y; Xu X; Ding R; Tang W; Sun Y; Wang X; Zhang Y; Wu J; Xie Y; Liu M; Wang Z; Yi F
Metabolism; 2024 Jan; 150():155724. PubMed ID: 37952690
[TBL] [Abstract][Full Text] [Related]
8. [Effects and mechanisms of total flavones of Abelmoschus manihot in improving insulin resistance and podocyte epithelial-mesenchymal transition in diabetic kidney disease based on IRS1/PI3K/Akt pathway].
Wang Y; Cao DW; Wan YG; Mu GL; Wu W; Fang QJ; Li YJ; Cha SY; Tu Y; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2646-2656. PubMed ID: 37282926
[TBL] [Abstract][Full Text] [Related]
9. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
[TBL] [Abstract][Full Text] [Related]
10. Glomerular podocytes in diabetic renal disease.
Podgórski P; Konieczny A; Lis Ł; Witkiewicz W; Hruby Z
Adv Clin Exp Med; 2019 Dec; 28(12):1711-1715. PubMed ID: 31851794
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease.
Tagaya M; Kume S; Yasuda-Yamahara M; Kuwagata S; Yamahara K; Takeda N; Tanaka Y; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Ishihara N; Nomura M; Araki SI; Maegawa H
Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166368. PubMed ID: 35202791
[TBL] [Abstract][Full Text] [Related]
12. Modes of podocyte death in diabetic kidney disease: an update.
Jiang A; Song A; Zhang C
J Nephrol; 2022 Jul; 35(6):1571-1584. PubMed ID: 35201595
[TBL] [Abstract][Full Text] [Related]
13. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
Ma RX; Zhao N; Zhang W
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
[TBL] [Abstract][Full Text] [Related]
14. [Effects and mechanisms of total flavones of Abelmoschus manihot in inhibiting podocyte necroptosis and renal fibrosis in diabetic kidney disease].
Chen JX; Fang QJ; Wan YG; Liu YL; Wang Y; Wu W; Tu Y; Wang MZ; Wang DG; Ge HT
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4137-4146. PubMed ID: 37802782
[TBL] [Abstract][Full Text] [Related]
15. The Evolving Importance of Insulin Signaling in Podocyte Health and Disease.
Lay AC; Coward RJM
Front Endocrinol (Lausanne); 2018; 9():693. PubMed ID: 30524379
[TBL] [Abstract][Full Text] [Related]
16. Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction.
Liu S; Yuan Y; Xue Y; Xing C; Zhang B
Front Cell Dev Biol; 2022; 10():832887. PubMed ID: 35321238
[TBL] [Abstract][Full Text] [Related]
17. The podocyte in diabetic kidney disease.
Stitt-Cavanagh E; MacLeod L; Kennedy C
ScientificWorldJournal; 2009 Oct; 9():1127-39. PubMed ID: 19838599
[TBL] [Abstract][Full Text] [Related]
18. Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney disease.
Jiang W; Gan C; Zhou X; Yang Q; Chen D; Xiao H; Dai L; Chen Y; Wang M; Yang H; Li Q
Cardiovasc Diabetol; 2023 Oct; 22(1):293. PubMed ID: 37891556
[TBL] [Abstract][Full Text] [Related]
19. Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease.
Shahzad K; Fatima S; Khawaja H; Elwakiel A; Gadi I; Ambreen S; Zimmermann S; Mertens PR; Biemann R; Isermann B
Kidney Int; 2022 Oct; 102(4):766-779. PubMed ID: 35779608
[TBL] [Abstract][Full Text] [Related]
20. The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.
Wu M; Yoon CY; Park J; Kim G; Nam BY; Kim S; Park JT; Han SH; Kang SW; Yoo TH
Diabetologia; 2024 Jun; ():. PubMed ID: 38879617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
